8-K current report · filed Oct 29, 2026

DaVita (DVA) 8-K Current Report: October 29, 2026

Item EX-99.1Item 2.02DVA overview

Short answer

DaVita (DVA) filed an 8-K current report with the SEC on October 29, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). DaVita announced financial results for the quarter ended September 30, 2026.

DaVita 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • DaVita announced financial results for the quarter ended September 30, 2026
  • Full revenue, earnings and operating details are in Exhibit 99.1, the attached earnings release

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $3.578B, operating income $499M, adjusted EPS $3.82, with adjusted operating margin 15.7%
  • Adjusted 2026 operating-income guidance raised to $2.175B-$2.250B from prior low of $2.150B
  • China impairment charge $62M reduced attributable net income by $27M, depressing GAAP EPS versus adjusted EPS
  • Patient care costs rose to $280.22 per treatment while revenue per treatment fell to $415.25, pressuring dialysis margins
  • Share repurchases accelerated: 0.6M shares for $111M in Q3, plus 0.5M shares for $87M through October 27

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other DaVita 8-K filings

Get the next DVA 8-K as it lands

Follow DVA for push alerts, or ask the research agent what this filing means.